Chiquita Brooks-LaSure, CMS director (Photo by Caroline Brehman/CQ Roll Call via AP Images)

In­fla­tion re­bates: CMS lays the ground rules for phar­ma com­pli­ance

The Cen­ters for Medicare and Med­ic­aid Ser­vices this af­ter­noon un­veiled its first tranche of guid­ance on how drug com­pa­nies will com­ply with new manda­to­ry re­bates — if they raise the prices for cer­tain drugs faster than the rate of in­fla­tion.

While in­dus­try has set the vast ma­jor­i­ty of its price in­creas­es be­low 10% in re­cent years, this new pro­vi­sion will like­ly lead to even small­er in­creas­es to avoid the re­bates.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.